Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Université Libre de Bruxelles
Bruselas, BélgicaPublicaciones en colaboración con investigadores/as de Université Libre de Bruxelles (9)
2022
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
2021
-
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
BMC Infectious Diseases, Vol. 21, Núm. 1
-
Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts
Critical care (London, England), Vol. 25, Núm. 1, pp. 87
2020
-
The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database
Critical Care, Vol. 24, Núm. 1
2018
-
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)
Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344
2017
-
Decision-Making on Withholding or Withdrawing Life Support in the ICU: A Worldwide Perspective
Chest, Vol. 152, Núm. 2, pp. 321-329
2014
-
An Insight into the Transcriptome of the Digestive Tract of the Bloodsucking Bug, Rhodnius prolixus
PLoS Neglected Tropical Diseases, Vol. 8, Núm. 1, pp. 27
-
Assessment of the worldwide burden of critical illness: The Intensive Care Over Nations (ICON) audit
The Lancet Respiratory Medicine, Vol. 2, Núm. 5, pp. 380-386
-
Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels
BMC Infectious Diseases, Vol. 14, Núm. 1